Resveratrol as antioxidant in cardiac surgery: is there potential for clinical application?

1Gibbon JH. Application of a mechanical heart and lung apparatus to cardiac surgery. Minn Med 1954;37:171–85. PMID: 13154149 Gibbon JH Application of a mechanical heart and lung apparatus to cardiac surgery Minn Med 195437171 85 PMID: 13154149Search in Google Scholar

2Laffey JG, Boylan JF, Cheng DC. The systemic inflammatory response to cardiac surgery. Anesthesiology 2002;97:215–52. doi: 10.1097/00000542-200207000-00030 Laffey JG Boylan JF Cheng DC The systemic inflammatory response to cardiac surgery Anesthesiology 200297215 52 10.1097/00000542-200207000-00030Open DOISearch in Google Scholar

3Wan S, LeClerc JL, Vincent JL. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest 1997;112:676–92. doi: 10.1378/ chest.112.3.676 Wan S LeClerc JL Vincent JL Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies Chest 1997112676 92 10.1378/ chest.112.3.676Open DOISearch in Google Scholar

4Milei J, Forcada P, Fraga CG, Grana DR, Iannelli G, Chiariello M, Tritto I, Ambrosio G. Relationship between oxidative stress, lipid peroxidation, and ultrastructural damage in patients with coronary artery disease undergoing cardioplegic arrest/reperfusion. Cardiovasc Res 2007;73:710–9. doi: 10.1016/j.cardiores.2006.12.007 Milei J Forcada P Fraga CG Grana DR Iannelli G Chiariello M Tritto I Ambrosio G Relationship between oxidative stress, lipid peroxidation, and ultrastructural damage in patients with coronary artery disease undergoing cardioplegic arrest/reperfusion Cardiovasc Res 200773710 9 10.1016/j.cardiores.2006.12.007Open DOISearch in Google Scholar

5Leong JY, van der Merwe J, Pepe S, Bailey M, Perkins A, Lymbury R, Esmore D, Marasco S, Rosenfeldt F. Perioperative metabolic therapy improves redox status and outcomes in cardiac surgery patients: a randomized trial. Heart Lung Circ 2010;19:584–91. doi: 10.1016/j. hlc.2010.06.65 Leong JY van der Merwe J Pepe S Bailey M Perkins A Lymbury R Esmore D Marasco S Rosenfeldt F Perioperative metabolic therapy improves redox status and outcomes in cardiac surgery patients: a randomized trial Heart Lung Circ 201019584 91 10.1016/j. hlc.2010.06.65Open DOISearch in Google Scholar

6Renaud S, de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992;339:1523–6. doi: 10.1016/0140-6736(92)91277-f Renaud S de Lorgeril M Wine, alcohol, platelets, and the French paradox for coronary heart disease Lancet 19923391523 6 10.1016/0140-6736(92)91277-fOpen DOISearch in Google Scholar

7Siemann EH, Creasy LL. Concentration of the phytoalexin resveratrol in wine. Am J Enol Vitic 1992;43:49–52. Siemann EH Creasy LL Concentration of the phytoalexin resveratrol in wine Am J Enol Vitic 19924349 52Search in Google Scholar

8Chen H, Tuck T, Ji X, Zhou X, Kelly G, Cuerrier A, Zhang J. Quality assessment of Japanese knotweed (Fallopia japonica) grown on Prince Edward Island as a source of resveratrol. J Agric Food Chem 2013;61:6383–92. doi: 10.1021/jf4019239 Chen H Tuck T Ji X Zhou X Kelly G Cuerrier A Zhang J Quality assessment of Japanese knotweed (Fallopia japonica) grown on Prince Edward Island as a source of resveratrol J Agric Food Chem 2013616383 92 10.1021/jf4019239Open DOISearch in Google Scholar

9Cottart CH, Nivet-Antoine V, Laguillier-Morizot C, Beaudeux JL. Resveratrol bioavailability and toxicity in humans. Mol Nutr Food Res 2010;54:7–16. doi: 10.1002/mnfr.200900437 Cottart CH Nivet-Antoine V Laguillier-Morizot C Beaudeux JL Resveratrol bioavailability and toxicity in humans Mol Nutr Food Res 2010547 16 10.1002/mnfr.200900437Open DOISearch in Google Scholar

10Walle T, Hsieh F, DeLegge MH, Oatis JEJr, Walle UK. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metabol Disposit 2004;32:1377–82. Walle T Hsieh F DeLegge MH Oatis JEJr Walle UK High absorption but very low bioavailability of oral resveratrol in humans Drug Metabol Disposit 2004321377 82Search in Google Scholar

11Juan ME, Vinardell MP, Planas JM. The daily oral administration of high doses of trans-resveratrol to rats for 28 days is not harmful. J Nutr 2002;132:257–60. doi: 10.1093/jn/132.2.257 Juan ME Vinardell MP Planas JM The daily oral administration of high doses of trans-resveratrol to rats for 28 days is not harmful J Nutr 2002132257 60 10.1093/jn/132.2.257Open DOISearch in Google Scholar

12Dirks Naylor AJ. Celular effects of resveratrol in skeletal muscle. Life Sci 2009;84:637–40. doi: 10.1016/j.lfs.2009.02.011 Dirks Naylor AJ Celular effects of resveratrol in skeletal muscle Life Sci 200984637 40 10.1016/j.lfs.2009.02.011Open DOISearch in Google Scholar

13Bradamante S, Barenghi L, Villa A. Cardiovascular protective effects of resveratrol. Cardiovasc Drug Rev 2004;22:169–88. doi: 10.1111/ j.1527-3466.2004.tb00139.x Bradamante S Barenghi L Villa A Cardiovascular protective effects of resveratrol Cardiovasc Drug Rev 200422169 88 10.1111/ j.1527-3466.2004.tb00139.xOpen DOISearch in Google Scholar

14Hao HD, He LR. Mechanisms of cardiovascular protection by resveratrol. J Med Food 2004;7:290–8. doi: 10.1089/jmf.2004.7.290 Hao HD He LR Mechanisms of cardiovascular protection by resveratrol J Med Food 20047290 8 10.1089/jmf.2004.7.290Open DOISearch in Google Scholar

15Wang Z, Zou J, Huang Y, Cao K, Xu Y, Wu JM. Effect of resveratrol on platelet aggregation in vivo and in vitro. Chin Med J (Engl) 2002;115:378–80. PMID: 11940369 Wang Z Zou J Huang Y Cao K Xu Y Wu JM Effect of resveratrol on platelet aggregation in vivo and in vitro Chin Med J (Engl) 2002115378 80 PMID: 11940369Search in Google Scholar

16Chu LM, Lassaletta AD, Robich MP, Sellke FW. Resveratrol in the prevention and treatment of coronary artery disease. Curr Atheroscler Rep 2011;13:439–46. doi: 10.1007/s11883-011-0202-3 Chu LM Lassaletta AD Robich MP Sellke FW Resveratrol in the prevention and treatment of coronary artery disease Curr Atheroscler Rep 201113439 46 10.1007/s11883-011-0202-3Open DOISearch in Google Scholar

17Plauth A, Geikowski A, Cichon S, Wowro SJ, Liedgens L, Rousseau M, Weidner C, Fuhr L, Kliem M, Jenkins G, Lotito S, Wainwright LJ, Sauer S. Hormetic shifting of redox environment by pro-oxidative resveratrol protects cells against stress. Free Radic Biol Med 2016;99:608–22. doi: 10.1016/j.freeradbiomed.2016.08.006 Plauth A Geikowski A Cichon S Wowro SJ Liedgens L Rousseau M Weidner C Fuhr L Kliem M Jenkins G Lotito S Wainwright LJ Sauer S Hormetic shifting of redox environment by pro-oxidative resveratrol protects cells against stress Free Radic Biol Med 201699608 22 10.1016/j.freeradbiomed.2016.08.006Open DOISearch in Google Scholar

18Xu H-C, Lv W, Wang L-M, Ye P, Hu J. Early protection by resveratrol in rat lung transplantation. Med Sci Monit 2019;25:760–70. doi: 10.12659/MSM.912345 Xu H-C Lv W Wang L-M Ye P Hu J Early protection by resveratrol in rat lung transplantation Med Sci Monit 201925760 70 10.12659/MSM.912345Open DOISearch in Google Scholar

19Cheng L, Jin Z, Zhao R, Ren K, Deng C, Yu S. Resveratrol attenuates inflammation and oxidative stress induced by myocardial ischemia-reperfusion injury: role of Nrf2/ARE pathway. Int J Clin Exp Med 2015;8:10420–8. PMCID: PMC4565215 Cheng L Jin Z Zhao R Ren K Deng C Yu S Resveratrol attenuates inflammation and oxidative stress induced by myocardial ischemia-reperfusion injury: role of Nrf2/ARE pathway Int J Clin Exp Med 2015810420 8 PMCID: PMC4565215Search in Google Scholar

20Penumathsa SV, Maulik N. Resveratrol: a promising agent in promoting cardioprotection against coronary heart disease. Can J Physiol Pharmacol 2009;87:275–86. doi: 10.1139/Y09-013 Penumathsa SV Maulik N Resveratrol: a promising agent in promoting cardioprotection against coronary heart disease Can J Physiol Pharmacol 200987275 86 10.1139/Y09-013Open DOISearch in Google Scholar

21Wang XL, Li T, Li JH, Miao SY, Xiao XZ. The effects of resveratrol on inflammation and oxidative stress in a rat model of chronic obstructive pulmonary disease. Molecules 2017;22(9):1529. doi: 10.3390/molecules22091529 Wang XL Li T Li JH Miao SY Xiao XZ The effects of resveratrol on inflammation and oxidative stress in a rat model of chronic obstructive pulmonary disease Molecules 20172291529 10.3390/molecules22091529Open DOISearch in Google Scholar

22Usta E, Mustafi M, Walker T, Ziemer G. Resveratrol suppresses apoptosis in intact human cardiac tissue - in vitro model simulating extracorporeal circulation. J Cardiovasc Surg 2011;52:399–409. PMID: 21577194 Usta E Mustafi M Walker T Ziemer G Resveratrol suppresses apoptosis in intact human cardiac tissue - in vitro model simulating extracorporeal circulation J Cardiovasc Surg 201152399 409 PMID: 21577194Search in Google Scholar

23Zhou R, Yi L, Ye X, Zeng X, Liu K, Qin Y, Zhang Q, Mi M. Resveratrol ameliorates lipid droplet accumulation in liver through a SIRT1/ ATF6-dependent mechanism. Cell Physiol Biochem 2018;51:2397–420. doi: 10.1159/000495898 Zhou R Yi L Ye X Zeng X Liu K Qin Y Zhang Q Mi M Resveratrol ameliorates lipid droplet accumulation in liver through a SIRT1/ ATF6-dependent mechanism Cell Physiol Biochem 2018512397 420 10.1159/000495898Open DOISearch in Google Scholar

24Lin KH, Hsiao G, Shih CM, Chou DS, Sheu JR. Mechanisms of resveratrol-induced platelet apoptosis. Cardiovasc Res 2009;83:575–85. doi: 10.1093/cvr/cvp139 Lin KH Hsiao G Shih CM Chou DS Sheu JR Mechanisms of resveratrol-induced platelet apoptosis Cardiovasc Res 200983575 85 10.1093/cvr/cvp139Open DOISearch in Google Scholar

25Rivera L, Morón R, Zarzuelo A, Galisteo M. Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats. Biochem Pharmacol 2009;77:1053–63. doi: 10.1016/j.bcp.2008.11.027 Rivera L Morón R Zarzuelo A Galisteo M Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats Biochem Pharmacol 2009771053 63 10.1016/j.bcp.2008.11.027Open DOISearch in Google Scholar

26Hausenblas HA, Schoulda JA, Smoliga JM. Resveratrol treatment as an adjunct to pharmacological management in type 2 diabetes mellitus - systematic review and meta-analysis. Mol Nutr Food Res 2015;59:147–59. doi: 10.1002/mnfr.201400173 Hausenblas HA Schoulda JA Smoliga JM Resveratrol treatment as an adjunct to pharmacological management in type 2 diabetes mellitus - systematic review and meta-analysis Mol Nutr Food Res 201559147 59 10.1002/mnfr.201400173Open DOISearch in Google Scholar

27Fogacci F, Tocci G, Presta V, Fratter A, Borghi C, Cicero AFG. Effect of resveratrol on blood pressure: a systematic review and meta-analysis of randomized, controlled, clinical trials. Crit Rev Food Sci Nutr 2019;59:1605–18. doi: 10.1080/10408398.2017.1422480 Fogacci F Tocci G Presta V Fratter A Borghi C Cicero AFG Effect of resveratrol on blood pressure: a systematic review and meta-analysis of randomized, controlled, clinical trials Crit Rev Food Sci Nutr 2019591605 18 10.1080/10408398.2017.1422480Open DOISearch in Google Scholar

28Haghighatdoost F, Hariri M. Effect of resveratrol on lipid profile: an updated systematic review and meta-analysis on randomized clinical trials. Pharmacol Res 2018;129:141–50. doi: 10.1016/j.phrs.2017.12.033 Haghighatdoost F Hariri M Effect of resveratrol on lipid profile: an updated systematic review and meta-analysis on randomized clinical trials Pharmacol Res 2018129141 50 10.1016/j.phrs.2017.12.033Open DOISearch in Google Scholar

29Hong S-P, Choi D-H, Choi J-S. Effects of resveratrol on the pharmacokinetics of diltiazem and its major metabolite, desacetyldiltiazem, in rats. Cardiovasc Ther 2008;26:269–75. doi: 10.1111/j.1755-5922.2008.00060.x Hong S-P Choi D-H Choi J-S Effects of resveratrol on the pharmacokinetics of diltiazem and its major metabolite, desacetyldiltiazem, in rats Cardiovasc Ther 200826269 75 10.1111/j.1755-5922.2008.00060.xOpen DOISearch in Google Scholar

30Tomé-Carneiro J, Gonzálvez M, Larrosa M, Yáñez-Gascón MJ, García-Almagro FJ, Ruiz-Ros JA, García-Conesa MT, Tomás-Barberán FA, Espín JC. One-year consumption of a grape nutraceutical containing resveratrol improves the inflammatory and fibrinolytic status of patients in primary prevention of cardiovascular disease. Am J Cardiol 2012;110:356–63. doi: 10.1016/j.amjcard.2012.03.030 Tomé-Carneiro J Gonzálvez M Larrosa M Yáñez-Gascón MJ García-Almagro FJ Ruiz-Ros JA García-Conesa MT Tomás-Barberán FA Espín JC One-year consumption of a grape nutraceutical containing resveratrol improves the inflammatory and fibrinolytic status of patients in primary prevention of cardiovascular disease Am J Cardiol 2012110356 63 10.1016/j.amjcard.2012.03.030Open DOISearch in Google Scholar

31Öztürk Y, Günaydın C, Yalçın F, Nazıroğlu M, Braidy N. Resveratrol enhances apoptotic and oxidant effects of paclitaxel through TRPM2 channel activation in DBTRG glioblastoma cells. Oxid Med Cell Longev 2019;2019:4619865. doi: 10.1155/2019/4619865 Öztürk Y Günaydın C Yalçın F Nazıroğlu M Braidy N Resveratrol enhances apoptotic and oxidant effects of paclitaxel through TRPM2 channel activation in DBTRG glioblastoma cells Oxid Med Cell Longev 201920194619865 10.1155/2019/4619865Open DOISearch in Google Scholar

32Zhu Y, Feng B, He S, Su Z, Zheng G. Resveratrol combined with total flavones of hawthorn alleviate the endothelial cells injury after coronary bypass graft surgery. Phytomedicine 2018;40:20–6. doi: 10.1016/j.phymed.2017.12.037 Zhu Y Feng B He S Su Z Zheng G Resveratrol combined with total flavones of hawthorn alleviate the endothelial cells injury after coronary bypass graft surgery Phytomedicine 20184020 6 10.1016/j.phymed.2017.12.037Open DOISearch in Google Scholar

33Penumathsa SV, Koneru S, Samuel SM, Maulik G, Bagchi D, Yet SF, Menon VP, Maulik N. Strategic targets to induce neovascularization by resveratrol in hypercholesterolemic rat myocardium: role of caveolin-1, endothelial nitric oxide synthase, hemeoxygenase-1, and vascular endothelial growth factor. Free Radic Biol Med 2008;45:1027–34. doi: 10.1016/j.freeradbiomed.2008.07.012 Penumathsa SV Koneru S Samuel SM Maulik G Bagchi D Yet SF Menon VP Maulik N Strategic targets to induce neovascularization by resveratrol in hypercholesterolemic rat myocardium: role of caveolin-1, endothelial nitric oxide synthase, hemeoxygenase-1, and vascular endothelial growth factor Free Radic Biol Med 2008451027 34 10.1016/j.freeradbiomed.2008.07.012Open DOISearch in Google Scholar

34Fujitaka K, Otani H, Jo F, Jo H, Nomura E, Iwasaki M, Nishikawa M, Iwasaka T, Das D. Modified resveratrol Longevinex improves endothelial function in adults with metabolic syndrome receiving standard treatment. Nutr Res 2011;31:842–7. doi: 10.1016/j. nutres.2011.09.028 Fujitaka K Otani H Jo F Jo H Nomura E Iwasaki M Nishikawa M Iwasaka T Das D Modified resveratrol Longevinex improves endothelial function in adults with metabolic syndrome receiving standard treatment Nutr Res 201131842 7 10.1016/j. nutres.2011.09.028Open DOISearch in Google Scholar

35Ekshyyan VP, Hebert VY, Khandelwal A, Dugas TR. Resveratrol inhibits rat aortic vascular smooth muscle cell proliferation via estrogen receptor dependent nitric oxide production. J Cardiovasc Pharmacol 2007;50:83–93. doi: 10.1097/FJC.0b013e318059ae8 Ekshyyan VP Hebert VY Khandelwal A Dugas TR Resveratrol inhibits rat aortic vascular smooth muscle cell proliferation via estrogen receptor dependent nitric oxide production J Cardiovasc Pharmacol 20075083 93 10.1097/FJC.0b013e318059ae8Open DOISearch in Google Scholar